Skip to main content

Select Drug Profiles

Adding Linagliptin to Basal Insulin Reduces Hypoglycemia in Older Patients with Type 2 Diabetes

Novel Predictors of Outcomes in Diabetes

Reductions in HbA1c Levels, Hypoglycemia, and Weight with Linagliptin in Patients with Type 2 Diabetes and Renal Impairment

Lifestyle Intervention Beneficial in Patients with Diabetes, but Not for CV Parameters

FDA Approves Mirvaso, First and Only Treatment Available for Erythema in Rosacea

Emerging Therapies for the Treatment of Rosacea

Caroline Helwick

Access and the Affordable Care Act

Jennifer Malin, MD, PhD

ACOs Challenges in Oncology Care

John E. Hennessy, CMPE

Keeping up with Clinical Pathways

Matthew C. Palmgren, PharmD

Value Propositon of Personalized Medicine

John E. Hennessy, CMPE

Page 167 of 244
Results 1661 - 1670 of 2438